NEWARK, Calif. (AP) _ Protagonist Therapeutics Inc. (PTGX) on Wednesday reported a loss of $30.8 million in its second quarter.
The Newark, California-based company said it had a loss of 69 cents per share.
The results missed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 62 cents per share.
The biopharmaceutical company posted revenue of $2.3 million in the period.
Protagonist Therapeutics shares have more than doubled since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $48.98, more than tripling in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PTGX at https://www.zacks.com/ap/PTGX
Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News